Rockwell Medical (RMTI) Profit After Tax (2010 - 2026)
Rockwell Medical (RMTI) posted Profit After Tax of -$1.6 million for Q1 2026, down 189.71% on a QoQ basis from -$554000.0 in Q4 2025, and down 5.94% year-over-year from -$1.7 million in Q1 2025.
Rockwell Medical (RMTI) Profit After Tax (2010 - 2026) Analysis & Trends
Rockwell Medical's Profit After Tax history runs 17 years deep, the most recent figure standing at -$1.6 million for Q1 2026.
- Quarterly Profit After Tax fell 5.94% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 1946.97% YoY) and the FY2025 annual result came in at -$5.3 million, down 1007.08% from the prior year.
- Profit After Tax was -$1.6 million for Q1 2026 at Rockwell Medical, down from -$554000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $1.7 million in Q3 2024 and bottomed at -$7.2 million in Q1 2022.
- A 5-year average of -$2.0 million and a median of -$1.7 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 188.89% — and 2025, when it slumped 534.99%.
- Rockwell Medical's Profit After Tax stood at -$2.4 million in 2022, then surged by 35.99% to -$1.5 million in 2023, then soared by 50.0% to -$756000.0 in 2024, then advanced by 26.72% to -$554000.0 in 2025, then tumbled by 189.71% to -$1.6 million in 2026.
- Business Quant data shows RMTI's Profit After Tax at -$1.6 million in Q1 2026, -$554000.0 in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Rockwell Medical | 28.18 Mn | 4.29 Mn | 2.90 Mn | -1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | -554,000.00 |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | -756,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 343,000.00 |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | -3.31 Mn |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -2.36 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.97 Mn |
| Mar 31, 2022 | -7.16 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Sep 30, 2021 | -7.58 Mn |
| Jun 30, 2021 | -8.40 Mn |